Synthesis and Structure–Activity Relationships of the Novel Antimalarials 5‑Pyridinyl-4(1H)‑Pyridones
Malaria is still one of the most prevalent parasitic infections in the world, with half of the world’s population at risk for malaria. The effectiveness of current antimalarial therapies, even that of the most recent class of antimalarial drugs (artemisinin-combination therapies, ACTs), is under con...
Gespeichert in:
Veröffentlicht in: | Journal of medicinal chemistry 2018-04, Vol.61 (8), p.3422-3435 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3435 |
---|---|
container_issue | 8 |
container_start_page | 3422 |
container_title | Journal of medicinal chemistry |
container_volume | 61 |
creator | Bueno, José M Calderon, Félix Chicharro, Jesús De la Rosa, Juan C Díaz, Beatriz Fernández, Jorge Fiandor, José M Fraile, María T García, Mercedes Herreros, Esperanza García-Pérez, Adolfo Lorenzo, Milagros Mallo, Araceli Puente, Margarita Saadeddin, Anas Ferrer, Santiago Angulo-Barturen, Iñigo Burrows, Jeremy N León, María L |
description | Malaria is still one of the most prevalent parasitic infections in the world, with half of the world’s population at risk for malaria. The effectiveness of current antimalarial therapies, even that of the most recent class of antimalarial drugs (artemisinin-combination therapies, ACTs), is under continuous threat by the spread of resistant Plasmodium strains. As a consequence, there is still an urgent requirement for new antimalarial drugs. We previously reported the identification of 4(1H)-pyridones as a novel series with potent antimalarial activities. The low solubility was identified as an issue to address. In this paper, we describe the synthesis and biological evaluation of 4(1H)-pyridones with potent antimalarial activities in vitro and in vivo and improved pharmacokinetic profiles. Their main structural novelties are the presence of polar moieties, such as hydroxyl groups, and the replacement of the lipophilic phenyl rings with pyridines on their lipophilic side chains. |
doi_str_mv | 10.1021/acs.jmedchem.7b01256 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2019812461</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2019812461</sourcerecordid><originalsourceid>FETCH-LOGICAL-a3756-54b3e5a3244044ad376e98f26763a2ddeda10d76803eac32277b977e59a301d43</originalsourceid><addsrcrecordid>eNp9kEtOwzAQhi0EgvK4AUJZwiJlPHbiZFkhXhICxGMdufFUNaRJsROk7HoFxA05CYa2LFmNNPP9M5qPsUMOQw7IT3Xphy8zMuWUZkM1Bo5JusEGPEGIZQZykw0AEGNMUeywXe9fAEBwFNtsB_Mky3OBA_b62NftlLz1ka5N9Ni6rmw7R1-Lz1HZ2nfb9tEDVbq1Te2ndu6jZhKFQHTbvFMVjerWznSlndWVj5Kvxcd976yxdV_F8phfnaw7TU1-n21NAkYHq7rHni_On86u4pu7y-uz0U2shUrSOJFjQYkWKCVIqY1QKeXZBFOVCo3GkNEcjEozEKRLgajUOFeKklwL4EaKPXa83Dt3zVtHvi1m1pdUVbqmpvMFAs8zjjLlAZVLtHSN944mxdyFh1xfcCh-NBdBc7HWXKw0h9jR6kI3DrO_0NprAGAJ_MabztXh4f93fgMZFI-L</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2019812461</pqid></control><display><type>article</type><title>Synthesis and Structure–Activity Relationships of the Novel Antimalarials 5‑Pyridinyl-4(1H)‑Pyridones</title><source>ACS Publications</source><source>MEDLINE</source><creator>Bueno, José M ; Calderon, Félix ; Chicharro, Jesús ; De la Rosa, Juan C ; Díaz, Beatriz ; Fernández, Jorge ; Fiandor, José M ; Fraile, María T ; García, Mercedes ; Herreros, Esperanza ; García-Pérez, Adolfo ; Lorenzo, Milagros ; Mallo, Araceli ; Puente, Margarita ; Saadeddin, Anas ; Ferrer, Santiago ; Angulo-Barturen, Iñigo ; Burrows, Jeremy N ; León, María L</creator><creatorcontrib>Bueno, José M ; Calderon, Félix ; Chicharro, Jesús ; De la Rosa, Juan C ; Díaz, Beatriz ; Fernández, Jorge ; Fiandor, José M ; Fraile, María T ; García, Mercedes ; Herreros, Esperanza ; García-Pérez, Adolfo ; Lorenzo, Milagros ; Mallo, Araceli ; Puente, Margarita ; Saadeddin, Anas ; Ferrer, Santiago ; Angulo-Barturen, Iñigo ; Burrows, Jeremy N ; León, María L</creatorcontrib><description>Malaria is still one of the most prevalent parasitic infections in the world, with half of the world’s population at risk for malaria. The effectiveness of current antimalarial therapies, even that of the most recent class of antimalarial drugs (artemisinin-combination therapies, ACTs), is under continuous threat by the spread of resistant Plasmodium strains. As a consequence, there is still an urgent requirement for new antimalarial drugs. We previously reported the identification of 4(1H)-pyridones as a novel series with potent antimalarial activities. The low solubility was identified as an issue to address. In this paper, we describe the synthesis and biological evaluation of 4(1H)-pyridones with potent antimalarial activities in vitro and in vivo and improved pharmacokinetic profiles. Their main structural novelties are the presence of polar moieties, such as hydroxyl groups, and the replacement of the lipophilic phenyl rings with pyridines on their lipophilic side chains.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/acs.jmedchem.7b01256</identifier><identifier>PMID: 29589932</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Animals ; Antimalarials - chemical synthesis ; Antimalarials - chemistry ; Antimalarials - pharmacokinetics ; Antimalarials - pharmacology ; Female ; Mice ; Molecular Structure ; Parasitic Sensitivity Tests ; Plasmodium falciparum - drug effects ; Plasmodium yoelii - drug effects ; Pyridones - chemical synthesis ; Pyridones - chemistry ; Pyridones - pharmacokinetics ; Pyridones - pharmacology ; Structure-Activity Relationship</subject><ispartof>Journal of medicinal chemistry, 2018-04, Vol.61 (8), p.3422-3435</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a3756-54b3e5a3244044ad376e98f26763a2ddeda10d76803eac32277b977e59a301d43</citedby><cites>FETCH-LOGICAL-a3756-54b3e5a3244044ad376e98f26763a2ddeda10d76803eac32277b977e59a301d43</cites><orcidid>0000-0002-5411-0382 ; 0000-0003-0486-6883 ; 0000-0003-0498-9066</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.7b01256$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01256$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29589932$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bueno, José M</creatorcontrib><creatorcontrib>Calderon, Félix</creatorcontrib><creatorcontrib>Chicharro, Jesús</creatorcontrib><creatorcontrib>De la Rosa, Juan C</creatorcontrib><creatorcontrib>Díaz, Beatriz</creatorcontrib><creatorcontrib>Fernández, Jorge</creatorcontrib><creatorcontrib>Fiandor, José M</creatorcontrib><creatorcontrib>Fraile, María T</creatorcontrib><creatorcontrib>García, Mercedes</creatorcontrib><creatorcontrib>Herreros, Esperanza</creatorcontrib><creatorcontrib>García-Pérez, Adolfo</creatorcontrib><creatorcontrib>Lorenzo, Milagros</creatorcontrib><creatorcontrib>Mallo, Araceli</creatorcontrib><creatorcontrib>Puente, Margarita</creatorcontrib><creatorcontrib>Saadeddin, Anas</creatorcontrib><creatorcontrib>Ferrer, Santiago</creatorcontrib><creatorcontrib>Angulo-Barturen, Iñigo</creatorcontrib><creatorcontrib>Burrows, Jeremy N</creatorcontrib><creatorcontrib>León, María L</creatorcontrib><title>Synthesis and Structure–Activity Relationships of the Novel Antimalarials 5‑Pyridinyl-4(1H)‑Pyridones</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Malaria is still one of the most prevalent parasitic infections in the world, with half of the world’s population at risk for malaria. The effectiveness of current antimalarial therapies, even that of the most recent class of antimalarial drugs (artemisinin-combination therapies, ACTs), is under continuous threat by the spread of resistant Plasmodium strains. As a consequence, there is still an urgent requirement for new antimalarial drugs. We previously reported the identification of 4(1H)-pyridones as a novel series with potent antimalarial activities. The low solubility was identified as an issue to address. In this paper, we describe the synthesis and biological evaluation of 4(1H)-pyridones with potent antimalarial activities in vitro and in vivo and improved pharmacokinetic profiles. Their main structural novelties are the presence of polar moieties, such as hydroxyl groups, and the replacement of the lipophilic phenyl rings with pyridines on their lipophilic side chains.</description><subject>Animals</subject><subject>Antimalarials - chemical synthesis</subject><subject>Antimalarials - chemistry</subject><subject>Antimalarials - pharmacokinetics</subject><subject>Antimalarials - pharmacology</subject><subject>Female</subject><subject>Mice</subject><subject>Molecular Structure</subject><subject>Parasitic Sensitivity Tests</subject><subject>Plasmodium falciparum - drug effects</subject><subject>Plasmodium yoelii - drug effects</subject><subject>Pyridones - chemical synthesis</subject><subject>Pyridones - chemistry</subject><subject>Pyridones - pharmacokinetics</subject><subject>Pyridones - pharmacology</subject><subject>Structure-Activity Relationship</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtOwzAQhi0EgvK4AUJZwiJlPHbiZFkhXhICxGMdufFUNaRJsROk7HoFxA05CYa2LFmNNPP9M5qPsUMOQw7IT3Xphy8zMuWUZkM1Bo5JusEGPEGIZQZykw0AEGNMUeywXe9fAEBwFNtsB_Mky3OBA_b62NftlLz1ka5N9Ni6rmw7R1-Lz1HZ2nfb9tEDVbq1Te2ndu6jZhKFQHTbvFMVjerWznSlndWVj5Kvxcd976yxdV_F8phfnaw7TU1-n21NAkYHq7rHni_On86u4pu7y-uz0U2shUrSOJFjQYkWKCVIqY1QKeXZBFOVCo3GkNEcjEozEKRLgajUOFeKklwL4EaKPXa83Dt3zVtHvi1m1pdUVbqmpvMFAs8zjjLlAZVLtHSN944mxdyFh1xfcCh-NBdBc7HWXKw0h9jR6kI3DrO_0NprAGAJ_MabztXh4f93fgMZFI-L</recordid><startdate>20180426</startdate><enddate>20180426</enddate><creator>Bueno, José M</creator><creator>Calderon, Félix</creator><creator>Chicharro, Jesús</creator><creator>De la Rosa, Juan C</creator><creator>Díaz, Beatriz</creator><creator>Fernández, Jorge</creator><creator>Fiandor, José M</creator><creator>Fraile, María T</creator><creator>García, Mercedes</creator><creator>Herreros, Esperanza</creator><creator>García-Pérez, Adolfo</creator><creator>Lorenzo, Milagros</creator><creator>Mallo, Araceli</creator><creator>Puente, Margarita</creator><creator>Saadeddin, Anas</creator><creator>Ferrer, Santiago</creator><creator>Angulo-Barturen, Iñigo</creator><creator>Burrows, Jeremy N</creator><creator>León, María L</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5411-0382</orcidid><orcidid>https://orcid.org/0000-0003-0486-6883</orcidid><orcidid>https://orcid.org/0000-0003-0498-9066</orcidid></search><sort><creationdate>20180426</creationdate><title>Synthesis and Structure–Activity Relationships of the Novel Antimalarials 5‑Pyridinyl-4(1H)‑Pyridones</title><author>Bueno, José M ; Calderon, Félix ; Chicharro, Jesús ; De la Rosa, Juan C ; Díaz, Beatriz ; Fernández, Jorge ; Fiandor, José M ; Fraile, María T ; García, Mercedes ; Herreros, Esperanza ; García-Pérez, Adolfo ; Lorenzo, Milagros ; Mallo, Araceli ; Puente, Margarita ; Saadeddin, Anas ; Ferrer, Santiago ; Angulo-Barturen, Iñigo ; Burrows, Jeremy N ; León, María L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a3756-54b3e5a3244044ad376e98f26763a2ddeda10d76803eac32277b977e59a301d43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Animals</topic><topic>Antimalarials - chemical synthesis</topic><topic>Antimalarials - chemistry</topic><topic>Antimalarials - pharmacokinetics</topic><topic>Antimalarials - pharmacology</topic><topic>Female</topic><topic>Mice</topic><topic>Molecular Structure</topic><topic>Parasitic Sensitivity Tests</topic><topic>Plasmodium falciparum - drug effects</topic><topic>Plasmodium yoelii - drug effects</topic><topic>Pyridones - chemical synthesis</topic><topic>Pyridones - chemistry</topic><topic>Pyridones - pharmacokinetics</topic><topic>Pyridones - pharmacology</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bueno, José M</creatorcontrib><creatorcontrib>Calderon, Félix</creatorcontrib><creatorcontrib>Chicharro, Jesús</creatorcontrib><creatorcontrib>De la Rosa, Juan C</creatorcontrib><creatorcontrib>Díaz, Beatriz</creatorcontrib><creatorcontrib>Fernández, Jorge</creatorcontrib><creatorcontrib>Fiandor, José M</creatorcontrib><creatorcontrib>Fraile, María T</creatorcontrib><creatorcontrib>García, Mercedes</creatorcontrib><creatorcontrib>Herreros, Esperanza</creatorcontrib><creatorcontrib>García-Pérez, Adolfo</creatorcontrib><creatorcontrib>Lorenzo, Milagros</creatorcontrib><creatorcontrib>Mallo, Araceli</creatorcontrib><creatorcontrib>Puente, Margarita</creatorcontrib><creatorcontrib>Saadeddin, Anas</creatorcontrib><creatorcontrib>Ferrer, Santiago</creatorcontrib><creatorcontrib>Angulo-Barturen, Iñigo</creatorcontrib><creatorcontrib>Burrows, Jeremy N</creatorcontrib><creatorcontrib>León, María L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bueno, José M</au><au>Calderon, Félix</au><au>Chicharro, Jesús</au><au>De la Rosa, Juan C</au><au>Díaz, Beatriz</au><au>Fernández, Jorge</au><au>Fiandor, José M</au><au>Fraile, María T</au><au>García, Mercedes</au><au>Herreros, Esperanza</au><au>García-Pérez, Adolfo</au><au>Lorenzo, Milagros</au><au>Mallo, Araceli</au><au>Puente, Margarita</au><au>Saadeddin, Anas</au><au>Ferrer, Santiago</au><au>Angulo-Barturen, Iñigo</au><au>Burrows, Jeremy N</au><au>León, María L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and Structure–Activity Relationships of the Novel Antimalarials 5‑Pyridinyl-4(1H)‑Pyridones</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2018-04-26</date><risdate>2018</risdate><volume>61</volume><issue>8</issue><spage>3422</spage><epage>3435</epage><pages>3422-3435</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><abstract>Malaria is still one of the most prevalent parasitic infections in the world, with half of the world’s population at risk for malaria. The effectiveness of current antimalarial therapies, even that of the most recent class of antimalarial drugs (artemisinin-combination therapies, ACTs), is under continuous threat by the spread of resistant Plasmodium strains. As a consequence, there is still an urgent requirement for new antimalarial drugs. We previously reported the identification of 4(1H)-pyridones as a novel series with potent antimalarial activities. The low solubility was identified as an issue to address. In this paper, we describe the synthesis and biological evaluation of 4(1H)-pyridones with potent antimalarial activities in vitro and in vivo and improved pharmacokinetic profiles. Their main structural novelties are the presence of polar moieties, such as hydroxyl groups, and the replacement of the lipophilic phenyl rings with pyridines on their lipophilic side chains.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>29589932</pmid><doi>10.1021/acs.jmedchem.7b01256</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0002-5411-0382</orcidid><orcidid>https://orcid.org/0000-0003-0486-6883</orcidid><orcidid>https://orcid.org/0000-0003-0498-9066</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-2623 |
ispartof | Journal of medicinal chemistry, 2018-04, Vol.61 (8), p.3422-3435 |
issn | 0022-2623 1520-4804 |
language | eng |
recordid | cdi_proquest_miscellaneous_2019812461 |
source | ACS Publications; MEDLINE |
subjects | Animals Antimalarials - chemical synthesis Antimalarials - chemistry Antimalarials - pharmacokinetics Antimalarials - pharmacology Female Mice Molecular Structure Parasitic Sensitivity Tests Plasmodium falciparum - drug effects Plasmodium yoelii - drug effects Pyridones - chemical synthesis Pyridones - chemistry Pyridones - pharmacokinetics Pyridones - pharmacology Structure-Activity Relationship |
title | Synthesis and Structure–Activity Relationships of the Novel Antimalarials 5‑Pyridinyl-4(1H)‑Pyridones |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T12%3A24%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20Structure%E2%80%93Activity%20Relationships%20of%20the%20Novel%20Antimalarials%205%E2%80%91Pyridinyl-4(1H)%E2%80%91Pyridones&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Bueno,%20Jose%CC%81%20M&rft.date=2018-04-26&rft.volume=61&rft.issue=8&rft.spage=3422&rft.epage=3435&rft.pages=3422-3435&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/acs.jmedchem.7b01256&rft_dat=%3Cproquest_cross%3E2019812461%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2019812461&rft_id=info:pmid/29589932&rfr_iscdi=true |